Yale university researchers have successfully used a drug approved for ‘Rheumatoid Arthritis to treat ‘VITILIGO’ where skin loses its pigmentation or colour and white patches appear.

Current treatments include steroid creams and light therapy but are not totally effective.

‘Tofacitinib’, which was also used for alopecia was tried and the patient recovered almost completely without suffering any adverse side effects.

-Health magazine-